Apis Capital Management


Tokenized Hedge Fund Based On Stellar

Pre Sale – June 1st to June 27th


This is NOT a blockchain project. It is an “Asset Backed Token built on Stellar.

The Apis Token is the first tokenized hedge fund strategy, focused on an algorithmic, signal based volatility trading strategy, with a proven track record. The Apis Token is built on Stellar, the most efficient, secure and fastest blockchain protocol currently available.

Imagine you have a real estate building and each token represents a portion of the ownership, so you get rent every month and a big chunk of money when it sells. The same thing is for Apis Token. You own a portion of the ACM Fund, and receive money as the fund makes profits. The Token is actually “shares”, so the technology itself is Stellar.

The company and the founders have been featured in Business Insider and various media publications.


Edgar Radjabli: Managed a $2 million healthcare practice and a $6 million hedge fund – https://www.linkedin.com/in/dr-edgar-radjabli-740a246/

Vincent Sarullo: Manages Tower Fund Services which administers over $3billionn in hedge fund and real estate funds – https://www.linkedin.com/in/vincent-sarullo-9565ab7/

Elizabeth White: is the CEO of the White Company, which runs the White Wallet exchange platform – https://www.linkedin.com/in/thewhitecompany/

As of June 22, 2018 – 10,000 members

Apis Token Investments Balance is currently: $1,700,000 – Click Here

The current supply of Apis Tokens is: 2,125,000 APIS –Click Here

The Hedge Fund and its trading strategy have been live in January 2016

Coin Strength/Transactions Per Second – 1000 TPS based on Stellar

The performance of coin is based on the trading strategy and algorithmic AI trading system which is proprietary intellectual property. This strategy has returned 70% per year on average for almost 3 years, and they expect this to continue. Apis is NOT related to cryptocurrency trading so it will keep going up even when the rest of the crypto market goes down.

After interview with – Dr. Edgar Radjabli